Overview of inflammatory bowel disease in Australia in the last 50 years.
Inflammatory diseases of the intestine, including Crohn's disease, ulcerative colitis, and celiac disease are now very common in Australia and remain major challenges for clinicians. Australian (and New Zealand) clinicians and scientists have made considerable contributions to our current understanding of these diseases over the last 50 years, including pathogenesis (such as the 'butyrate hypothesis', 'endoplasmic reticulum (ER) stress', and the identification of the peptide sequences that incite celiac disease), true population epidemiology (albeit in New Zealand), precise clinical observation, new investigative tools, innovative new potential therapies, influential clinical drug trials (such as triple antibiotics for Crohn's disease), and a dietary approach with efficacy for functional gut symptoms (the low FODMAP diet). Underpinning the success has been clinical excellence and adaptation of clinicians to the changing landscape of disease severity and therapeutic options. The future is indeed bright if such trends continue.
Gibson
Peter R
PR
Monash University Department of Medicine, Box Hill Hospital, Box Hill, Victoria, Australia. peter.gibson@med.monash.edu.au
D001315:Australia / Q000453:epidemiology; D005762:Gastroenterology / Q000266:history* / Q000639:trends; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000266:history* / Q000628:therapy; D009520:New Zealand / Q000453:epidemiology; D011237:Predictive Value of Tests; D012307:Risk Factors; D016896:Treatment Outcome